Your body adjusts to the compound over time, side effects diminish, and metabolic benefits accumulate
Drugs with narrow therapeutic windows, oral contraceptives, and time-sensitive medications are most likely to be impacted
It targets both GLP-1 and GIP receptors and may help people lose even more weight than semaglutide in some cases
Studied for actin sequestration, cell migration, and angiogenesis in preclinical models
The TRIUMPH phase 3 development program is testing the medication for obstructive sleep apnea, chronic weight loss, and knee osteoarthritis
The prescribing criteria are similar for these medications, so as long as your health circumstances havent changed since you last requested Mounjaro treatment, you should be eligible for Wegovy as well